Intra-ventral tegmental area or intracerebroventricular orexin-A increases the intra-cranial self-stimulation threshold via activation of the corticotropin-releasing factor system in rats

European Journal of Neuroscience

Volumn 34, Issue 5, 2011, Pages 816-826

  Hata, Toshimichi ^a,b   Chen, Jihuan ^b,c   Ebihara, Kosuke ^d   Date, Yukari ^e   Ishida, Yasushi ^d   Nakahara, Daiichiro ^b  

^a DOSHISHA UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MIYAZAKI   (Japan)

^e UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Amygdala; Brain reward system; Dopamine; Microdialysis; Ventral tegmental area

Indexed keywords

ASTRESSIN; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; FOS ANTIBODY; OREXIN A; PROTEIN ANTIBODY; PROTEIN FOS; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL ACTIVATION; CELL COUNT; CELL LABELING; CONTROLLED STUDY; DOPAMINE UPTAKE; HEMISPHERIC DOMINANCE; HORMONE ACTION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LATERAL HYPOTHALAMUS; MALE; MICRODIALYSIS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REWARD; STRIA TERMINALIS; TISSUE DISTRIBUTION; VENTRAL TEGMENTUM;

AMYGDALA; ANIMALS; BEHAVIOR, ANIMAL; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE; INFUSIONS, INTRAVENTRICULAR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; REWARD; SELF STIMULATION; VENTRAL TEGMENTAL AREA;

EID: 80052453252     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2011.07808.x     Document Type: Article

References (66)

1. Al-Barazanji, K.A., Wilson, S., Baker, J., Jessop, D.S. & Harbuz, M.S. (2001) Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats. J. Neuroendocrinol., 13, 421-424.
2. Asan, E., Yilmazer-Hanke, D.M., Eliava, M., Hantsch, M., Lesch, K.P. & Schmitt, A. (2005) The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat. Neuroscience, 131, 953-967.
3. Aston-Jones, G., Smith, R.J., Sartor, G.C., Moorman, D.E., Massi, L., Tahsili-Fahadan, P. & Richardson, K.A. (2010) Lateral hypothalamic orexin/hypocretin neurons: a role in reward-seeking and addiction. Brain Res., 1314, 74-90.
4. Balcita-Pedicino, J.J. & Sesack, S.R. (2007) Orexin axons in the rat ventral tegmental area synapse infrequently onto dopamine and γ-aminobutyric acid neurons. J. Comp. Neurol., 503, 668-684.
5. Borgland, S.L., Taha, S.A., Sarti, F., Fields, H.L. & Bonci, A. (2006) Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron, 49, 589-601.
6. Boutrel, B., Kenny, P.J., Specio, S.E., Martin-Fardon, R., Markou, A., Koob, G.F. & de Lecea, L. (2005) Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc. Natl. Acad. Sci. USA, 102, 19168-19173.
7. Bruijnzeel, A.W., Zislis, G., Wilson, C. & Gold, M.S. (2007) Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. Neuropsychopharmacology, 32, 955-963.
8. Bruijnzeel, A.W., Prado, M. & Isaac, S. (2009) Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse. Biol. Psychiatry, 66, 110-117.
9. Bruijnzeel, A.W., Small, E., Pasek, T.M. & Yamada, H. (2010) Corticotropin-releasing factor mediates the dysphoria-like state associated with alcohol withdrawal in rats. Behav. Brain Res., 210, 288-291.
10. Bubser, M., Fadel, J.R., Jackson, L.L., Meador-Woodruff, J.H., Jing, D. & Deutch, A.Y. (2005) Dopaminergic regulation of orexin neurons. Eur. J. Neurosci., 21, 2993-3001.
11. Chemelli, R.M., Willie, J.T., Sinton, C.M., Elmquist, J.K., Scammell, T., Lee, C., Richardson, J.A., Williams, S.C., Xiong, Y., Kisanuki, Y., Fitch, T.E., Nakazato, M., Hammer, R.E., Saper, C.B. & Yanagisawa, M. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell, 98, 437-451.
12. Chen, J., Nakamura, M., Kawamura, T., Takahashi, T. & Nakahara, D. (2006) Roles of pedunculopontine tegmental cholinergic receptors in brain stimulation reward in the rat. Psychopharmacology (Berl), 184, 514-522.
13. Cheung, S., Ballew, J.R., Moore, K.E. & Lookingland, K.J. (1998) Contribution of dopamine neurons in the medial zona incerta to the innervation of the central nucleus of the amygdala, horizontal diagonal band of Broca and hypothalamic paraventricular nucleus. Brain Res., 808, 174-181.
14. Date, Y., Ueta, Y., Yamashita, H., Yamaguchi, H., Matsukura, S., Kangawa, K., Sakurai, T., Yanagisawa, M. & Nakazato, M. (1999) Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. USA, 96, 748-753.
15. Day, H.E., Vittoz, N.M., Oates, M.M., Badiani, A., Watson, S.J. Jr, Robinson, T.E. & Akil, H. (2002) A 6-hydroxydopamine lesion of the mesostriatal dopamine system decreases the expression of corticotropin releasing hormone and neurotensin mRNAs in the amygdala and bed nucleus of the stria terminalis. Brain Res., 945, 151-159.
16. Eliava, M., Yilmazer-Hanke, D. & Asan, E. (2003) Interrelations between monoaminergic afferents and corticotropin-releasing factor-immunoreactive neurons in the rat central amygdaloid nucleus: ultrastructural evidence for dopaminergic control of amygdaloid stress systems. Histochem. Cell Biol., 120, 183-197.
17. Erb, S. (2010) Evaluation of the relationship between anxiety during withdrawal and stress-induced reinstatement of cocaine seeking. Prog. Neuropsychopharmacol. Biol. Psychiatry, 34, 798-807.
18. Estabrooke, I.V., McCarthy, M.T., Ko, E., Chou, T.C., Chemelli, R.M., Yanagisawa, M., Saper, C.B. & Scammell, T.E. (2001) Fos expression in orexin neurons varies with behavioral state. J. Neurosci., 21, 1656-1662.
19. Fadel, J. & Deutch, A.Y. (2002) Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience, 111, 379-387.
20. Fadel, J., Bubser, M. & Deutch, A.Y. (2002) Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. J. Neurosci., 22, 6742-6746.
21. Fibiger, H.C., LePiane, F.G., Jakubovic, A. & Phillips, A.G. (1987) The role of dopamine in intracranial self-stimulation of the ventral tegmental area. J. Neurosci., 7, 3888-3896.
22. Georgescu, D., Zachariou, V., Barrot, M., Mieda, M., Willie, J.T., Eisch, A.J., Yanagisawa, M., Nestler, E.J. & DiLeone, R.J. (2003) Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J. Neurosci., 23, 3106-3111.
23. Harris, G.C. & Aston-Jones, G. (2003) Enhanced morphine preference following prolonged abstinence: association with increased Fos expression in the extended amygdala. Neuropsychopharmacology, 28, 292-299.
24. Harris, G.C. & Aston-Jones, G. (2006) Arousal and reward: a dichotomy in orexin function. Trends Neurosci., 29, 571-577.
25. Harris, G.C., Wimmer, M. & Aston-Jones, G. (2005) A role for lateral hypothalamic orexin neurons in reward seeking. Nature, 437, 556-559.
26. Hollander, J.A., Lu, Q., Cameron, M.D., Kamenecka, T.M. & Kenny, P.J. (2008) Insular hypocretin transmission regulates nicotine reward. Proc. Natl. Acad. Sci. USA, 105, 19480-19485.
27. Ida, T., Nakahara, K., Murakami, T., Hanada, R., Nakazato, M. & Murakami, N. (2000) Possible involvement of orexin in the stress reaction in rats. Biochem. Biophys. Res. Commun., 270, 318-323.
28. Ishida, Y., Hashiguchi, H., Ishizuka, Y., Todaka, K., Kuwahara, I., Mitsuyama, Y. & Nishimori, T. (2000) Basal expression of c-Fos and Zif268 in the rat basal ganglia: immunohistochemical characterization of striatal Zif268-positive neurons. Eur. J. Neurosci., 12, 771-775.
29. Ishida, Y., Nakamura, M., Ebihara, K., Hoshino, K., Hashiguchi, H., Mitsuyama, Y., Nishimori, T. & Nakahara, D. (2001) Immunohistochemical characterisation of Fos-positive cells in brainstem monoaminergic nuclei following intracranial self-stimulation of the medial forebrain bundle in the rat. Eur. J. Neurosci., 13, 1600-1608.
30. Ishida, Y., Nakahara, D., Hashiguchi, H., Nakamura, M., Ebihara, K., Takeda, R., Nishimori, T. & Niki, H. (2002) Fos expression in GABAergic cells and cells immunopositive for NMDA receptors in the inferior and superior colliculi following audiogenic seizures in rats. Synapse, 46, 100-107.
31. Jászberényi, M., Bujdosó, E., Pataki, I. & Telegdy, G. (2000) Effects of orexins on the hypothalamic-pituitary-adrenal system. J. Neuroendocrinol., 12, 1174-1178.
32. Kenny, P.J. & Markou, A. (2006) Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology, 31, 1203-1211.
33. Koob, G.F. & Le Moal, M. (2006) Animal models of drug addiction. In Koob, G.F. & Le Moal, M. (Eds), Neurobiology of Addiction. Academic Press, London, pp. 23-67.
34. Korotkova, T.M., Sergeeva, O.A., Eriksson, K.S., Haas, H.L. & Brown, R.E. (2003) Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J. Neurosci., 23, 7-11.
35. de Lecea, L., Kilduff, T.S., Peyron, C., Gao, X., Foye, P.E., Danielson, P.E., Fukuhara, C., Battenberg, E.L., Gautvik, V.T., Bartlett, F.S. 2nd, Frankel, W.N., van den Pol, A.N., Bloom, F.E., Gautvik, K.M. & Sutcliffe, J.G. (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA, 95, 322-327.
36. Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P.J., Nishino, S. & Mignot, E. (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 98, 365-376.
37. Macey, D.J., Koob, G.F. & Markou, A. (2000) CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist. Brain Res., 866, 82-91.
38. Maj, M., Turchan, J., Smialowska, M. & Przewlocka, B. (2003) Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala. Neuropeptides, 37, 105-110.
39. Marcinkiewcz, C.A., Prado, M.M., Isaac, S.K., Marshall, A., Rylkova, D. & Bruijnzeel, A.W. (2009) Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats. Neuropsychopharmacology, 34, 1743-1752.
40. Martínez, G.S., Smale, L. & Nunez, A.A. (2002) Diurnal and nocturnal rodents show rhythms in orexinergic neurons. Brain Res., 955, 1-7.
41. Meloni, E.G., Gerety, L.P., Knoll, A.T., Cohen, B.M. & Carlezon, W.A. Jr. (2006) Behavioral and anatomical interactions between dopamine and corticotropin-releasing factor in the rat. J. Neurosci., 26, 3855-3863.
42. Merlo-Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G.F. & Weiss, F. (1995) Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci., 15, 5439-5447.
43. Nair, S.G., Golden, S.A. & Shaham, Y. (2008) Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-administration and reinstatement of food seeking in rats. Br. J. Pharmacol., 154, 406-416.
44. Nakahara, D., Ishida, Y., Nakamura, M., Kuwahara, I., Todaka, K. & Nishimori, T. (1999) Regional differences in desensitization of c-Fos expression following repeated self-stimulation of the medial forebrain bundle in the rat. Neuroscience, 90, 1013-1020.
45. Narita, M., Nagumo, Y., Hashimoto, S., Narita, M., Khotib, J., Miyatake, M., Sakurai, T., Yanagisawa, M., Nakamachi, T., Shioda, S. & Suzuki, T. (2006) Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J. Neurosci., 26, 398-405.
46. Narita, M., Nagumo, Y., Miyatake, M., Ikegami, D., Kurahashi, K. & Suzuki, T. (2007) Implication of protein kinase C in the orexin-induced elevation of extracellular dopamine levels and its rewarding effect. Eur. J. Neurosci., 25, 1537-1545.
47. Paxinos, G. & Watson, C. (1998) The Rat Brain in Stereotaxic Coordinates, 4th Edn. Academic Press, San Diego.
48. Peyron, C., Tighe, D.K., van den Pol, A.N., de Lecea, L., Heller, H.C., Sutcliffe, J.G. & Kilduff, T.S. (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci., 18, 9996-10015.
49. Phelix, C.F., Liposits, Z. & Paull, W.K. (1994) Catecholamine-CRF synaptic interaction in a septal bed nucleus: afferents of neurons in the bed nucleus of the stria terminalis. Brain Res. Bull, 33, 109-119.
50. R Development Core Team (2008) R: A Language and Environment for Statistical Computing. R. Foundation for Statistical Computing, Vienna, Austria. Available from.
51. Richards, J.K., Simms, J.A., Steensland, P., Taha, S.A., Borgland, S.L., Bonci, A. & Bartlett, S.E. (2008) Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl), 199, 109-117.
52. Richter, R.M. & Weiss, F. (1999) In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse, 32, 254-261.
53. Rodríguez de Fonseca, F., Carrera, M.R., Navarro, M., Koob, G.F. & Weiss, F. (1997) Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science, 276, 2050-2054.
54. Russell, S.H., Small, C.J., Dakin, C.L., Abbott, C.R., Morgan, D.G., Ghatei, M.A. & Bloom, S.R. (2001) The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats. J. Neuroendocrinol., 13, 561-566.
55. Sakamoto, F., Yamada, S. & Ueta, Y. (2004) Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul. Pept., 118, 183-191.
56. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., Williams, S.C., Richardson, J.A., Kozlowski, G.P., Wilson, S., Arch, J.R., Buckingham, R.E., Haynes, A.C., Carr, S.A., Annan, R.S., McNulty, D.E., Liu, W.S., Terrett, J.A., Elshourbagy, N.A., Bergsma, D.J. & Yanagisawa, M. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell, 92, 573-585.
57. Samson, W.K., Taylor, M.M., Follwell, M. & Ferguson, A.V. (2002) Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regul. Pept., 104, 97-103.
58. Shen, J., Tanida, M., Yao, J.F., Niijima, A. & Nagai, K. (2008) Biphasic effects of orexin-A on autonomic nerve activity and lipolysis. Neurosci. Lett., 444, 166-171.
59. Shih, C.D. & Chuang, Y.C. (2007) Nitric oxide and GABA mediate bi-directional cardiovascular effects of orexin in the nucleus tractus solitarii of rats. Neuroscience, 149, 625-635.
60. Smith, R.J., See, R.E. & Aston-Jones, G. (2009) Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. Eur. J. Neurosci., 30, 493-503.
61. Smith, R.J., Tahsili-Fahadan, P. & Aston-Jones, G. (2010) Orexin/hypocretin is necessary for context-driven cocaine-seeking. Neuropharmacology, 58, 179-184.
62. Vittoz, N.M., Schmeichel, B. & Berridge, C.W. (2008) Hypocretin/orexin preferentially activates caudomedial ventral tegmental area dopamine neurons. Eur. J. Neurosci., 28, 1629-1640.
63. Wang, B., You, Z.B. & Wise, R.A. (2009) Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network. Biol. Psychiatry, 65, 857-862.
64. Young, A.M. & Rees, K.R. (1998) Dopamine release in the amygdaloid complex of the rat, studied by brain microdialysis. Neurosci. Lett., 249, 49-52.
65. Zhou, Y., Bendor, J., Hofmann, L., Randesi, M., Ho, A. & Kreek, M.J. (2006) Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J. Endocrinol., 191, 137-145.
66. Zhou, Y., Cui, C.L., Schlussman, S.D., Choi, J.C., Ho, A., Han, J.S. & Kreek, M.J. (2008) Effects of cocaine place conditioning, chronic escalating-dose "binge" pattern cocaine administration and acute withdrawal on orexin/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague-Dawley rats. Neuroscience, 153, 1225-1234.